Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Shares of Moderna, along with other vaccine makers, dropped further this year as lawmakers advanced President Donald Trump's ...
Among the handful of drugmakers to advance a successful COVID-19 vaccine in 2020, Moderna—whose mRNA shot Spikevax was also ...
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.
Earnings: Discover insights into revenue shifts, cost reductions, 2027 product goals, RSV market strategies, and its broader ...
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today, we talk about that, as well as new cancer data from Corbus Pharma, Europe ...
Hosted on MSN3m
Journalists Talk Southern Health Care: HIV Drug Access, Medicaid Expansion, Vaccination RatesKFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback